Jill Herendeen, Pharm.D.

Senior Vice President, Regulatory Affairs

Jill Herendeen, PharmD is Silverback’s Senior Vice President of Regulatory Affairs. In her current role, Jill oversees the Regulatory Affairs, Medical Writing and Quality groups at Silverback.  Dr. Herendeen previously served as Senior Director Regulatory Affairs at Pharmacyclics where she led multiple global regulatory filings for Imbruvica across several advanced B-cell malignancies.  Before joining Pharmacyclics, she served as a global regulatory leader at Bristol Myers Squibb on a number of immuno-oncology assets.  She has also held various clinical and regulatory positions at Amgen working on several early, mid-stage and late-stage development assets. Dr. Herendeen received her Pharm.D. from University of Washington followed by a pharmacy practice residency at University of North Carolina (UNC), Chapel Hill and fellowship training in drug development at UNC & GlaxoSmithKline.

© Copyright 2022 - Silverback Therapeutics®️ | All Rights Reserved | Terms of Use